EVALUATION OF ANTIDIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF CITRULLUS COLOCYNTHIS
Keywords:
Diabetes mellitus , Citrullus colocynthis , Streptozocin , Glibenclamide, Antidiabetic activityAbstract
The plant which is selected for studies is Citrullus colocynthis. These plants are available in large quantities in desert area of Rajasthan and different region of the world. The pharmacological studies on diabetes mellitus, hyperlipidemia, fever, bacteria, wound healing activities and antioxidant activities of the plants have been tested and evaluated for various disease treatments like diabetes, fever, obesity and other many various disorders. The main focus is given against streptozocin induced diabetes treatment in albino rats and comparison is done with standard drug glibenclamide.
Downloads
References
Meena M C et al (2014) Ethanobotanical studies of Citrullus colocynthis J of Medicinal Plants Studies 2(2) , 15-22
Maqsood Ahmed et al (2020) Insecticidal and biochemical composition of Citrullus colocynthis, nature research, Scientific report, 41548-019-57092-5
Akbarzadeh A. (2007), induction of diabetes by streptozotocin in rats, Indian J. of Clinical Biochem., 22 (02), 60-4.
Aalto M. and Aro R. (1997), Health related quality of life among insulin-dependent diabetics: disease-related and psychosocial correlates, Patient Edu., 30, 215-25.
Abubakar M. and Syed R. (2015), Antidiabetic potential of some less commonly used plants in traditional medicinal systems of India and Nigeria, J. of Intercult Ethnopharmacol., 04(01), 78-85.
Almdal T, Scharling H, and Jensen Js, Vestergaard H (2004): independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med; 164:1422–1426.
Ashok Sharma et al (2013), Antidiabetic and Antihyperlipidemic Activity of Cucurbita maxima Duchense (Pumpkin) Seeds on Streptozotocin Induced Diabetic Rats. J. of Pharmacognosy and Phytochemistry; Vol. 1 No. 6 -108- 116.
B. Dhar, K.V. Billore, O.P. Gupta., (2003) evaluation of some controversial Ayurvedic Drugs of Indian Pharmaceutical industry. Recent Progress of Indian Medicinal plants 1st edition Vol. 1. Page. 307-309.
B.N. Dhavan., (2002) Prioritising Indian Flora for drug development, IDMA Bulletin Vol. 33(6) Page. 140.
B.V.S. Lakshmi, N.Neelima, N.Kasthuri, V.Umarani, M. Sudhakar (2011), Antihyperlipidemic activity of Bauhinia purpurea extracts in hypercholesterolemic albino rats, Int.J. PharmTech Res.,3(3)
Balamurugan G and Shantha (2010). Effect of Erythrina variegata seed extract on hyperlipidemia elicited by high-fat diet in wistar rats. J. of Pharm Bioall Sci. 2010; 4: 350-5.
Barbara G Wells, Joseph T DiPiro, Terry L Schwinghammer, Cindy Hamilton (2005). Pharmacotherapy Hand book, 6th ed .McGraw-Hill publications. p. 88-89
Baron RB (2005). Lipid Abnormalities. In: Current Medical Diagnosis and Treatment. 44th ed. McGraw-Hill Company: 1202-13.35.
Kokate C.K., Purohit A.P., Gokhale S.B., Pharmacognosy.edi. 24th Nirali Prakashan, Pune, 2003; 120-121.
Tandon V., Kapoor B., Gupta B.M., Herbal drug research in India: A trend analysis using IJP as a marker (1995-August 2003). Indian J pharmacol, 2004; 36(2): 99-100.
Department of AYUSH. A gateway for information on Ayurveda, Yoga Naturopathy, Unani, Siddha and Homoeopathy.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
https://orcid.org/0009-0000-7855-3914